Weakly Electric Fish Assay for Anesthetic Screening

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for high-throughput, cost-effective assays to evaluate the neurophysiological effects of water-soluble general anesthetics, particularly for elderly patients who are more sensitive to lipid-soluble anesthetics like propofol, leading to complications such as delirium and cognitive decline.

Innovation Solution

An in vivo assay using the weakly electric fish Apteronotus leptorhynchus, where the effects of anesthetics on the pacemaker nucleus are evaluated by monitoring the frequency of the electric organ discharge (EOD), providing a behavioral proxy for neural activity at a systems level, with a setup that is significantly cheaper and faster than traditional physiological recording methods.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional in vivo or in vitro physiological recording methods are used, then measurement precision of neural activity is improved, but device complexity and cost increase significantly

Engineering Contradiction:
Improveneural activity measurementVSAvoidphysiological setup
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent uses the electric organ discharge (EOD) of the weakly electric fish as an intermediary signal to indirectly measure the neural activity of the pacemaker nucleus. Instead of directly recording complex neural signals, the EOD serves as a reliable proxy that reflects pacemaker nucleus frequency, simplifying the measurement setup while maintaining measurement precision.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates a behavioral copy of neural activity by measuring EOD frequency, which mirrors the pacemaker nucleus oscillation frequency. This copying approach allows researchers to assess neural activity effects through an external, easily measurable signal rather than direct neural recording, reducing device complexity.

Inventive Principle:
Principle #26Copying

2Reliability

If traditional physiological recording assays are used, then data quality is improved, but time required for screening increases

Engineering Contradiction:
Improveassay resultsVSAvoidscreening throughput
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The fish's own EOD serves as the measurement signal, eliminating the need for external stimulation or complex recording apparatus. The system is self-powered and self-signalizing, allowing continuous monitoring of pacemaker nucleus activity without interfering with the animal's natural state, thus improving both reliability and throughput.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The EOD provides continuous, real-time information about pacemaker nucleus frequency throughout the assay. This continuous signaling allows for dynamic monitoring of anesthetic effects over time without requiring repeated measurements or interruptions, increasing screening productivity while maintaining data reliability.

Inventive Principle:
Principle #20Continuity of useful action

3Measurement precision

If traditional physiological setups are established, then measurement accuracy is improved, but setup costs increase

Engineering Contradiction:
Improvefrequency measurementVSAvoidassay setup
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The EOD recording setup serves multiple functions: it measures pacemaker nucleus frequency, monitors fish health status, and provides a behavioral readout of anesthetic effects. This multi-functionality reduces the need for separate specialized equipment for each measurement type, lowering overall setup costs while maintaining measurement accuracy.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20240207454A1Neuro-behavioral assay for physiological evaluation of water-soluble anesthetics
Publication Date: 2024.06.27 NORTHEASTERN UNIV (US)
  • US20240207454A1 patent drawing
  • US20240207454A1 patent drawing
  • US20240207454A1 patent drawing

AI summary

Disclosed are a system and an in vivo assay for the physiological evaluation of water-soluble general anesthetics. The assay is based on the effects of anesthetics on the frequency of the pacemaker nucleus, an endogenous neural oscillator in the brainstem, of the weakly electric fish Apteronotus leptorhynchus.